Marc-Andre Langlois of the University of Ottawa in Canada will develop small molecules that combine together to form a toxic compound only when they enter an HIV-infected cell. Because the molecules are non-toxic for healthy cells, they could constitute promising candidates for a vaccine-based delivery system aimed at specifically eliminating HIV-infected cells.
Grant ID
OPP1036023
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False